Related Experiment Video
Updated: Feb 6, 2026

Employing Aeroponic Systems for the Clonal Propagation of Cannabis
Published on: December 1, 2021
The relationship between maternal cannabis use disorder diagnosis and the development of retinopathy of prematurity
Melanie Tran1, Rebecca J Baer2, Gretchen Bandoli3
1School of Medicine, University of California San Diego, La Jolla, California.
Insights
Maternal cannabis use disorder (CUD) did not significantly alter the risk of retinopathy of prematurity (ROP) in preterm infants. This study found no increased or decreased incidence of ROP in infants born to mothers with CUD.
Area of Science:
- Neonatal care
- Perinatal health
- Obstetrics
Background:
- Retinopathy of prematurity (ROP) is a significant cause of visual impairment in preterm infants.
- Cannabis use during pregnancy is a growing concern with potential implications for infant health outcomes.
Purpose of the Study:
- To investigate the association between maternal cannabis use disorder (CUD) and the incidence of retinopathy of prematurity (ROP) in preterm infants.
- To compare ROP rates in infants born to mothers with and without a diagnosis of CUD during pregnancy.
Main Methods:
- Retrospective cohort study utilizing the UC San Diego Study of Outcomes in Mothers and Infants (SOMI) database.
- Included preterm infants (22-<31 weeks gestation and/or <1500g birth weight) surviving to ROP screening age.
- Maternal CUD and infant ROP identified via ICD codes; adjusted relative risk (aRR) calculated using log-linear regression.
Main Results:
- 32.1% of infants born to mothers with CUD developed ROP versus 33.3% of infants born to mothers without CUD.
- No statistically significant difference in ROP incidence was observed between the two groups (aRR = 1.0; 95% CI, 0.9-1.1).
- Adjusted analysis controlling for covariates confirmed no increased or decreased risk of ROP associated with maternal CUD.
Conclusions:
- Preterm infants born to mothers with CUD are not at a higher or lower risk of developing retinopathy of prematurity.
- The findings suggest that maternal CUD, as diagnosed in this study, is not a significant risk factor for ROP in this vulnerable infant population.
Purpose:
To compare the incidence of retinopathy of prematurity (ROP) among preterm infants born to mothers with and without a cannabis use disorder (CUD) diagnosis.
Methods:
This retrospective cohort study used the UC San Diego Study of Outcomes in Mothers and Infants (SOMI) population-based database and restricted the sample to infants born between 22 and <31 weeks' gestation, and/or having birth weight of <1500 g, who survived to the appropriate age for ROP screening. Infant ROP and maternal CUD during pregnancy were identified from International Classification of Diseases diagnostic codes from hospital discharge records. Adjusted relative risk (aRR) of ROP was calculated using log-linear regression, comparing mothers with and without CUD while controlling for demographic and clinical factors.
Results:
Of the 997 infants born between 22 and <31 weeks to mothers with CUD, 32.1% developed ROP, compared with 33.3% of the 30,1113 infants born to mothers without CUD. Adjusting for maternal covariates, preterm infants born to mothers with CUD were not found to be at higher or lower risk of developing ROP than preterm infants born to mothers without CUD (aRR = 1.0; 95% CI, 0.9-1.1).
Conclusions:
In our study cohort, preterm infants born to mothers with CUD did not have an increased or decreased risk of developing ROP compared with those born to mothers without CUD.
Related Concept Videos
Relationship Formation
Ending Relationships
Relationship Growth
Social Relationships and Well-Being
Nursing Diagnosis
The nursing diagnosis focuses on evidence-based...
Close Relationships and Culture

